FI870435A - Nya 2-amino-3-formyl-furaner, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. - Google Patents

Nya 2-amino-3-formyl-furaner, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. Download PDF

Info

Publication number
FI870435A
FI870435A FI870435A FI870435A FI870435A FI 870435 A FI870435 A FI 870435A FI 870435 A FI870435 A FI 870435A FI 870435 A FI870435 A FI 870435A FI 870435 A FI870435 A FI 870435A
Authority
FI
Finland
Prior art keywords
furaner
nya
formyl
amino
foerfarande foer
Prior art date
Application number
FI870435A
Other languages
English (en)
Other versions
FI870435A0 (fi
Inventor
Walter Loesel
Otto Roos
Gerd Schnorrenberg
Dietrich Arndts
Franz-Josef Kuhn
Erich Lehr
Richard Reichl
Guenter Schingnitz
Georg Speck
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of FI870435A0 publication Critical patent/FI870435A0/fi
Publication of FI870435A publication Critical patent/FI870435A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
FI870435A 1986-02-03 1987-02-02 Nya 2-amino-3-formyl-furaner, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. FI870435A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863603194 DE3603194A1 (de) 1986-02-03 1986-02-03 Neue 2-amino-3-formyl-furane, verfahren zu ihrer herstellung und die enthaltenden pharmazeutischen zusammensetzungen

Publications (2)

Publication Number Publication Date
FI870435A0 FI870435A0 (fi) 1987-02-02
FI870435A true FI870435A (fi) 1987-08-04

Family

ID=6293224

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870435A FI870435A (fi) 1986-02-03 1987-02-02 Nya 2-amino-3-formyl-furaner, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.

Country Status (16)

Country Link
EP (1) EP0234329A1 (fi)
JP (1) JPS62185086A (fi)
KR (1) KR870007922A (fi)
AU (1) AU6823587A (fi)
CS (1) CS67287A2 (fi)
DD (1) DD260067A5 (fi)
DE (1) DE3603194A1 (fi)
DK (1) DK52687A (fi)
FI (1) FI870435A (fi)
HU (1) HU900157D0 (fi)
IL (1) IL81447A0 (fi)
NO (1) NO870408L (fi)
PL (1) PL263934A1 (fi)
PT (1) PT84240B (fi)
YU (1) YU13787A (fi)
ZA (1) ZA87730B (fi)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3143876A1 (de) * 1981-11-05 1983-05-11 Boehringer Ingelheim KG, 6507 Ingelheim Neue1-furyl-3,4-dihydroisochinoline diese enthaltende arzneimittel sowie verfahren zu deren herstellung und deren verwendung
DE3401018A1 (de) * 1984-01-13 1985-07-18 Boehringer Ingelheim KG, 6507 Ingelheim Verfahren zur herstellung von 5,6-dihydro-pyrrolo(2,1-a)isochinolinen

Also Published As

Publication number Publication date
PL263934A1 (en) 1988-07-21
NO870408L (no) 1987-08-04
JPS62185086A (ja) 1987-08-13
IL81447A0 (en) 1987-09-16
NO870408D0 (no) 1987-02-02
YU13787A (en) 1988-10-31
PT84240B (pt) 1991-02-08
EP0234329A1 (de) 1987-09-02
DK52687D0 (da) 1987-02-02
ZA87730B (en) 1988-10-26
PT84240A (de) 1987-03-01
DE3603194A1 (de) 1987-08-06
FI870435A0 (fi) 1987-02-02
HU900157D0 (en) 1990-03-28
KR870007922A (ko) 1987-09-22
CS67287A2 (en) 1990-10-12
DD260067A5 (de) 1988-09-14
AU6823587A (en) 1987-08-06
HUT47100A (en) 1989-01-30
DK52687A (da) 1987-08-04

Similar Documents

Publication Publication Date Title
FI860971A (fi) Nya sulfonylaminoetylfoereningar, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI862623A (fi) Nya 2-arylimidazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI874323A0 (fi) Nya imidazo-benzoxazinoner, deras framstaellning och dessa foereningar innehaollande laekemedel.
FI864879A0 (fi) Nya tiazolfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutisk blandning.
FI861153A (fi) Nya jodpropargyletrar, foerfarande foer deras framstaellning och deras anvaendning.
FI872841A0 (fi) Nya kromoforfoereningar, solskyddskompositioner och foerfarande foer hindrande av solbraenna.
FI870274A (fi) Nya alkan- och alkoxialkanderivat, foerfarande foer deras framstaellning och dessa foereningar innehaollande bekaempningsmedel foer insekter och kvalster.
FI875719A (fi) Nya alkansulfonanilidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI883347A0 (fi) Nya 5-aminometylen-2,4 -imidazolidindioner och 5-aminometylen-4-tionoimidazolidin-4-oner.
FI875086A0 (fi) Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI872897A (fi) Nya 4-pyridonderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.
FI862723A0 (fi) Nya sackarider, deras framstaellning och farmaceutiska sammansaettningar innehaollande desamma.
FI885056A0 (fi) Nya fluormetoxifenyldihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
FI885722A (fi) Nya kinolinderivat, foerfaranden foer framstaellning daerav och antibakteriella aemnen innehaollande desamma.
FI884225A0 (fi) Nya aminosyraestrar, foerfaranden foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning.
FI871812A0 (fi) Nya benzotiazinonderivat, deras framstaellningsfoerfarande dessa innehaollande laekemedel och deras anvaendning.
FI865190A (fi) Nya bensamider, foerfarande foer deras framstaellning och deras terapeutiska anvaendning.
FI875212A0 (fi) Nya aryloxi-3-amino-2-propanoler, deras framstaellning och anvaendning.
FI862970A (fi) Nya 11-metylen-estr-15-ener, foerfaranden foer deras framstaellning och farmaceutiska kompositioner.
FI874172A0 (fi) Nya aryloxi-aminoalkaner, deras framstaellning och anvaendning.
FI885057A0 (fi) Nya fluormetoxifenyldihydropyridiner, foerfaranden foer deras framstaellning och deras anvaendning i laekemedel.
FI870435A0 (fi) Nya 2-amino-3-formyl-furaner, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI873179A0 (fi) Nya tetrahydrobenzotiazolo -kinoliner, deras framstaellning och anvaendning.
FI874602A0 (fi) Nya jaestexpressionvektor foer ifn-omega, foerfarande foer deras framstaellning och deras anvaendning.
FI894315A0 (fi) Nya sulfonamider, foerfarande foer deras framstaellning och dessa nya sulfonamider innehaollande farmaceutiska kompositioner.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BOEHRINGER INGELHEIM KG